ARTICLE | Company News
King to pull Theelin NDA
December 21, 2001 8:00 AM UTC
KG will withdraw its NDA for Theelin estrone injectable suspension to treat moderate to severe vasomotor symptoms of menopause and vaginal and vulvar atrophy. KG said the FDA requested additional clin...